RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in RVL Pharmaceuticals plc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −5 vs. Q1 2023
- Shares held
- 24.1M
- −1.09M (−4.3%) vs. Q1 2023
- Total value
- $13.5M
- −$15.2M (−53.0%) vs. Q1 2023
- New holders
- 1
- 4 more added
- Sold out
- 6
- 13 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Athyrium Capital Management, LP | 14,600,444 | $8.18M | 5.31% | 00.0% | Unchanged |
| Rovida Advisors Inc. | 3,000,000 | $1.68M | 0.73% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 1,506,002 | $843.5K | 0.01% | −116,998−7.2% | Reduced |
| AIGH Capital Management LLC | 1,116,653 | $625.4K | 0.26% | −139,740−11.1% | Reduced |
| Morgan Stanley | 989,280 | $554.1K | 0.00% | −68,278−6.5% | Reduced |
| Renaissance Technologies LLC | 694,915 | $389.0K | 0.00% | −2,500−0.4% | Reduced |
| Geode Capital Management, LLC | 307,266 | $172.1K | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 278,654 | $156.1K | 0.09% | −44,175−13.7% | Reduced |
| UBS Oconnor LLC | 254,736 | $142.7K | 0.00% | −21,692−7.8% | Reduced |
| Vanguard Group Inc | 246,353 | $138.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 231,841 | $129.9K | 0.00% | +18,304+8.6% | Added |
| Scoggin Management LP | 160,007 | $89.6K | 0.16% | −339,993−68.0% | Reduced |
| Marietta Wealth Management, LLC | 120,000 | $67.2K | 0.01% | 00.0% | Unchanged |
| Titleist Asset Management, LLC | 87,642 | $49.1K | 0.01% | −17,361−16.5% | Reduced |
| State Street Corp | 78,687 | $44.1K | 0.00% | 00.0% | Unchanged |
| Insight Advisors, LLC | 75,646 | $42.4K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 72,899 | $40.8K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 55,095 | $30.9K | 0.00% | −17,569−24.2% | Reduced |
| Citadel Advisors LLC | 51,693 | $29.0K | 0.00% | +10,154+24.4% | Added |
| Raymond James Financial Services Advisors, Inc. | 29,519 | $16.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 23,541 | $13.2K | 0.00% | −136,870−85.3% | Reduced |
| LPL Financial LLC | 21,210 | $11.9K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 15,236 | $8.53K | 0.00% | +10+0.1% | Added |
| Charles Schwab Investment Management Inc | 13,322 | $7.46K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,078 | $6.76K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 11,103 | $6.22K | 0.00% | −6,682−37.6% | Reduced |
| SFMG, LLC | 10,000 | $5.60K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 10,000 | $5.60K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,780 | $2.68K | 0.00% | +2,135+80.7% | Added |
| Dakota Community Bank & Trust NA | 1,809 | $1.01K | 0.01% | −2,171−54.5% | Reduced |
| Royal Bank of Canada | 937 | $1.00K | 0.00% | +937 | New |
| Bank of America Corp | 1,720 | $963 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,187 | $665 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 225 | $126 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3 | $2 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 2 | $1 | 0.00% | −5−71.4% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −127,853−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −31,500−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −13,697−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,299−100.0% | Sold out |
| Tower View Investment Management & Research LLC | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |